Genetic evolution of enterovirus 71: epidemiological and pathological implications.
about
MicroRNA and Pathogenesis of Enterovirus InfectionDevelopment of Novel Vaccines against Enterovirus-71Conformational Plasticity of the 2A Proteinase from Enterovirus 71The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine DevelopmentClinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 InfectionHand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.Inferring nonneutral evolution from contrasting patterns of polymorphisms and divergences in different protein coding regions of enterovirus 71 circulating in Taiwan during 1998-2003.Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia.Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in miceA novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 geneTyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection.Producing infectious enterovirus type 71 in a rapid strategy.Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in miceEmergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China.Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09.Challenges to licensure of enterovirus 71 vaccines.Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010.Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interactionThe cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.Microchip capillary electrophoresis with laser-induced fluorescence combined with one-step duplex reverse-transcription polymerase chain reaction for the rapid detection of Enterovirus 71 and Coxsackievirus A16 in throat swab specimens.The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.Epidemiology and virologic investigation of human enterovirus 71 infection in the Republic of Korea from 2007 to 2012: a nationwide cross-sectional studyCoxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication.Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infectionSeroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China.A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.Enterovirus 71 maternal antibodies in infants, Taiwan.An siRNA screen for ATG protein depletion reveals the extent of the unconventional functions of the autophagy proteome in virus replication.Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China.Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis.Development of enterovirus 71 vaccines.Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong.Progress on the research and development of human enterovirus 71 (EV71) vaccines.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71.Enterovirus 71 transmission by exosomes establishes a productive infection in human neuroblastoma cells.
P2860
Q26769980-582C31D2-8398-43C2-82FD-00329C2184E5Q26771247-ABFB59C3-9BBC-42A1-8617-15E839CB3ED3Q27677562-8A39F416-191D-480E-8255-C5B1072AA6A1Q28066400-80A680D2-65E3-4C7C-852D-97E1BD117015Q28550208-F86935B9-3EA6-40BF-B117-9CB626CB9A7FQ30249022-F34105AC-BCD0-4BB4-9F08-2267C293643BQ30497073-054F72D6-66CA-4053-9F2B-1D78B1C3F1ABQ33599341-FDFC3D5C-8E0D-4699-8B0B-8834B1F28E93Q33646488-C7F46E05-A14B-4FB2-A4BD-0B01527D8711Q33685512-F8EB7B2F-8E08-4B9D-990A-731410D0DDF7Q33725572-19852E11-B988-4483-B1CE-7FCA45D505EAQ33747574-90F9B95B-2954-4BE6-81F1-369C5566C71AQ33942293-CFE4674E-7214-4686-952F-A67134ADD033Q33958090-00B70411-5B0C-409F-A79C-7ECAA273E0E8Q34085811-DA0572EB-6D83-416A-A013-9A2F1B77026FQ34163871-271BD48F-EEC5-4C2E-8AAC-381953BA2E1FQ34406820-C317BF01-2824-4ED2-A87C-56ECFBE1933CQ34415864-8EDFDC21-1D26-46F6-AFAA-62514CA0705CQ34576673-B68BC6F2-94A3-402E-9675-FDA7BC02803FQ34916727-4D9D27FC-1402-413A-8B1C-14282CB52064Q35048558-A039BA43-1172-4B0E-AAA7-FD5A5984C052Q35624818-9E768E6A-513E-4EE2-BABE-4F1FEBF8F5B7Q35826072-B920CEE8-DA7D-4CA1-BA00-214FBCE9F254Q35925175-CB88C92F-8687-4AF7-B492-5D38B7E33A17Q36107261-ECCB2D5E-EE1E-42F8-AB9E-85F8BDC8D842Q36387676-16D26DA3-C796-4FB5-92DC-C3C093BF8BFBQ36423598-538E94ED-549B-4133-965F-8D0D428E2661Q36535558-31EA3B6A-95CB-44B4-94C9-9723F2B54C9EQ36572065-2DA4E015-3068-43E5-95E0-B0992AC4DF41Q37164704-7F3918B5-B33A-422F-B4F0-11A602D4136CQ37216414-4768E505-5573-4341-AF4D-3A83CD0C01CEQ37245341-F7F5AC00-4BDC-4649-A3AD-A44F311C567CQ37333587-E6904379-4E82-423D-B6E5-1168138F36CDQ37458096-B42E70AF-21C4-444C-B4B5-53D070F46958Q37682898-F45E1605-26E5-4457-B5B3-547ED6D9A3AFQ37832197-32290D32-D2D6-4B4F-9681-A4ABD62708C6Q38068107-FFC1E264-6ABB-46A3-BE61-34BE5B020E8AQ38195326-4626A789-BE5C-4983-ADD3-16C200EF757AQ38728593-9721106A-55F4-4A03-BE23-2CB2E94D4C60Q38797295-43B7C5F7-DBFF-442D-8179-48FADEB2495F
P2860
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@ast
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@en
type
label
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@ast
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@en
prefLabel
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@ast
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@en
P2093
P2860
P356
P1476
Genetic evolution of enterovirus 71: epidemiological and pathological implications.
@en
P2093
C Y William Tong
Jon M Bible
Panagiotis Pantelidis
Paul K S Chan
P2860
P304
P356
10.1002/RMV.538
P577
2007-11-01T00:00:00Z